Fans

Chronic pain: long and inappropriate use of anti-inflammatories

For paediatricians and general practitioners, patient management requires an integrated multidisciplinary approach and the strengthening of territorial networks

Closeup view of pharmacist hand taking medicine box from the shelf in drug store. Pharmacy and health care.

3' min read

Translated by AI
Versione italiana

3' min read

Translated by AI
Versione italiana

Therapeutic appropriateness must be adequately checked and strengthened. Fimp and Fimmg, which represent family paediatricians and general practitioners, spoke about this during the recent Risk Management Forum in Arezzo, during which, in an event organised in collaboration with Angelini, the Italian physicians revealed the data on inappropriate use of non-steroidal anti-inflammatory drugs highlighted by the recent Osmed report.

In Italy, chronic pain affects about 13 million people, almost 20 per cent of the population, with strong repercussions in the health sector, significantly compromising the quality of life, generating social and work isolation, as well as determining a significant economic burden both for the individual and for the health system, causing absenteeism and a drop in productivity.

Loading...

Multidisciplinary management for chronic pain

The management of these patients therefore requires an integrated multidisciplinary approach, involving the general practitioner, the specialist, nurses, physiotherapists, psychologists and occupational therapists. Pain therapy networks have existed in Italy for years, structures that are still inadequate due to a lack of resources.

It is precisely for this reason that the Ministry of Health has issued Guidelines on the treatment of chronic non-oncological pain, reiterating the need to ensure access to care through the strengthening of networks and continuity of care between territory and hospital.

D'Avino: check the child's behaviour

Antonio D'Avino, Fimp president, also gave concrete operational indications on the management of childhood illnesses, also to avoid the often unnecessary presence in emergency rooms: 'When a fever rises,' he explained, 'the first thing to bear in mind is that in children it is often a natural defence response. That is why there is no need to bring it down if the little one, on the whole, is well enough. More than the number we read on the thermometer, the child's behaviour counts: if he is alert, lets himself be comforted, drinks and perhaps plays, even a high fever can be tolerated. If, on the other hand, the fever is very high and the child appears in pain or very dejected, it is a good idea to administer the antipyretic drugs recommended for paediatric use. If the fever persists for more than two or three days and tends to worsen instead of improving, it is right to speak to the paediatrician who can indicate the most appropriate course of action'.

The use of non-steroidal anti-inflammatory drugs is on the rise

A recent observational survey conducted by CliCon then assessed the use of non-steroidal anti-inflammatory drugs in Italy in the period 2019-2023. It reveals an inappropriate use of non-steroidal anti-inflammatory drugs (NSAIDs), among the most popular treatments for pain management.

Luca Degli Esposti, president of CliCon explained in this regard that 'we conducted an observational analysis of more than 12 million patients, the results of which, recently published, describe the patterns of NSAID use in Italy in the period 2019-2023. The proportion of patients treated increased from 1.9 % to 3 %, with an increase in consumption. Medium-low dosages were the most prescribed, the average duration of treatment was about three months, and one in five patients received more than one NSAID in the first 12 months'.

'In data updated to 2023,' he concluded, 'about half of NSAID users had known contraindications and 45% of patients at risk were not receiving gastroprotection. An integrated analysis also showed that 48% had potential contraindications or no documented indications'.

Copyright reserved ©
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti